Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Szwarc K et al. | Intramolecular transformation of an antifungal antibiotic nystatin A into its isomer, iso-nystatin A - structural and molecular modeling studies. | 2016 | Magn Reson Chem | pmid:27379602 |
Salyer AC et al. | Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen. | 2016 | PLoS ONE | pmid:26919709 |
Clark RS et al. | Validation of research trajectory 1 of an Exposome framework: Exposure to benzo(a)pyrene confers enhanced susceptibility to bacterial infection. | 2016 | Environ. Res. | pmid:26765097 |
Konecna A et al. | ERG6 gene deletion modifies Kluyveromyces lactis susceptibility to various growth inhibitors. | 2016 | Yeast | pmid:27668979 |
Graziano S et al. | The global effect of exposing bakers' yeast to 5-fluoruracil and nystatin; a view to Toxichip. | 2016 | Chemosphere | pmid:26694798 |
Kantarcioglu AS et al. | Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of Children with Suspected or Diagnosed Autism Spectrum Disorders and In Vitro Susceptibility Against Nystatin and Fluconazole. | 2016 | Mycopathologia | pmid:26442855 |
Kinoshita H et al. | Cryptic antifungal compounds active by synergism with polyene antibiotics. | 2016 | J. Biosci. Bioeng. | pmid:26323525 |
Hashemy SI et al. | Oxidative stress factors and C-reactive protein in patients with oral lichen planus before and 2 weeks after treatment. | 2016 | J. Oral Pathol. Med. | pmid:26058710 |
Marmiroli M et al. | A genome-wide nanotoxicology screen of Saccharomyces cerevisiae mutants reveals the basis for cadmium sulphide quantum dot tolerance and sensitivity. | 2016 | Nanotoxicology | pmid:25938282 |
Ellepola AN et al. | Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates. | 2016 | J Investig Clin Dent | pmid:25388637 |